High-resolution virus removal methodology and filtration capsule useful therefor
View Patent ↗The present invention provides a high-resolution membrane-based method for removing a virus from a manufactured protein-containing solution, the method being particularly characterized by its capacity to be performed quickly (i.e., as measured by flux) and efficiently (i.e., as measured by log reduction value, LRV). Towards such results, the present invention employs a plurality (i.e., greater than 2) of interfacially-contiguous asymmetric ultrafiltration membranes, the foremost of which is oriented with its “tight side” facing downstream. The present invention also provides a filtration capsule, useful in the conduct of the method, comprising a pleated tube formed of three interfacially-contiguous asymmetric ultrafiltration membranes.
1. A virus removal methodology, suitable for conducting a high-flux fluid separation of a virus from a protein in the course of biopharmaceutical manufacture, the methodology comprising the steps of:
(a) providing a filtration device comprising a housing having a fluid inlet and a filtrate outlet, and containing at least two interfacially contiguous asymmetric membranes, wherein:
(i) the asymmetric membranes are each substantially hydrophilic,
(ii) at least two of the asymmetric membranes are each capable of substantially selectively preventing the passage therethrough of said virus and substantially permitting the passage therethrough of said protein,
(iii) at least two of the asymmetric membranes have each a tight-side and an open-side, the average surface pore size of said tight-side being less than the average surface pore size of said open-side, and
(iv) the foremost asymmetric membrane is oriented such that fluid introduced into said housing through the fluid inlet commences passage through said foremost asymmetric membrane through its open-side;
(b) providing a manufactured protein-containing solution, wherein the predominant solute in said solution is said protein, and wherein the solution is prone to contamination by said virus; and
(c) flowing said manufactured protein-containing solution through said filtration device using a normal flow filtration mode under conditions sufficient to effect substantial passage of said protein through each of said asymmetric membranes and out of said housing through said filtrate outlet, whereby any of said virus contaminating said manufactured protein-containing solution, being substantially prevented from passage through said asymmetric membranes, is substantially removed therefrom.
2. The virus removal methodology of claim 1 , wherein the asymmetric membranes form a pleated tube.
3. The virus removal methodology of claim 1 , wherein each of said asymmetric membranes are substantially identical in their composition and porosity, and wherein the porosity of each of said asymmetric membranes is defined to enable performance of the virus removal methodology, yielding a log reduction value (LRV) greater than 6 and a protein passage greater than 98%.
4. The virus removal methodology of claim 1 , wherein the filtration device employed in said methodology is a filtration capsule comprising a tubular housing though which a fluid process stream can be conducted, the housing having said fluid inlet and said filtrate outlet, and containing a pleated tube compose of three interfacially-abutting asymmetric membranes, wherein the pleated tube is positioned within said process stream between said fluid inlet and said filtrate outlet.